| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects
Chul Won Choi, Min Ho Jeong, You-Soo Park, Cheol-Hun Son, Hong-Rae Lee, Eun-Kyoung Koh
Cancer Res Treat. 2019;51(2):464-473.   Published online June 6, 2018    DOI: https://doi.org/10.4143/crt.2018.186
                              Supplementary         Cited By 9
Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
Sanghyuk Song, Ji Hyun Chang, Hak Jae Kim, Yeon Sil Kim, Jin Hee Kim, Yong Chan Ahn, Jae-Sung Kim, Si Yeol Song, Sung Ho Moon, Moon June Cho, Seon Min Youn
Cancer Res Treat. 2017;49(3):688-694.   Published online October 31, 2016    DOI: https://doi.org/10.4143/crt.2016.219
                              Supplementary         Cited By 1
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery
Ciro Franzese, Davide Franceschini, Luca Cozzi, Giuseppe D’Agostino, Tiziana Comito, Fiorenza De Rose, Pierina Navarria, Pietro Mancosu, Stefano Tomatis, Antonella Fogliata, Marta Scorsetti
Cancer Res Treat. 2017;49(1):20-28.   Published online April 27, 2016    DOI: https://doi.org/10.4143/crt.2016.057
                                 Cited By 18
Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors
Sungkwang Park, Sanghwa Urm, Heunglae Cho
Cancer Res Treat. 2014;46(4):403-410.   Published online July 17, 2014    DOI: https://doi.org/10.4143/crt.2013.168
                                 Cited By 27
The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
Max Dahele, Suresh Senan
Cancer Res Treat. 2011;43(2):75-82.   Published online June 30, 2011    DOI: https://doi.org/10.4143/crt.2011.43.2.75
                                 Cited By 21
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Impact factor
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2PI